Clinical Trial Update: Engager Align Post-market Clinical Study

View source ↗

Summary

Medtronic's Engager Align post-market clinical study for transcatheter aortic valve replacement in patients with aortic valve stenosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Drugs mentioned

• Engager Transcatheter Aortic Valve System (Transcatheter aortic valve device)

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Aortic Valve Stenosis | Status: COMPLETED